Sangamo Therapeutics Announces Participation at Guggenheim Healthcare Talks: 2021 Genomic Medicines & Rare Disease
25 March 2021 - 11:30PM
Business Wire
Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine
company, announced today that management will participate in the
virtual Guggenheim Healthcare Talks: 2021 Genomic Medicines &
Rare Disease conference on April 1, 2021. Sangamo management is
expected to participate in a panel discussion at 10 a.m. Eastern
Time on April 1, 2021.
The event will be webcast live and available via an access link
on the Sangamo Therapeutics website in the Investors and Media
section under Events and Presentations. The event will also be
available on the Sangamo Therapeutics website after the event.
About Sangamo Therapeutics
Sangamo Therapeutics is committed to translating ground-breaking
science into genomic medicines with the potential to transform
patients’ lives using gene therapy, cell therapy, and genome
engineering. For more information about Sangamo, visit
www.sangamo.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20210325005156/en/
Investor Relations & Media
Inquiries Aron Feingold 628.252.7494
afeingold@sangamo.com
Sangamo Therapeutics (NASDAQ:SGMO)
Historical Stock Chart
From Apr 2024 to May 2024
Sangamo Therapeutics (NASDAQ:SGMO)
Historical Stock Chart
From May 2023 to May 2024